Microbix J (MBX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 102 | 108 | 107 | 102 | 102 |
| Income taxes - deferred | -90 | -66 | -66 | -133 | N/A |
| Accounts receivable | 945 | 184 | 197 | -465 | 527 |
| Other Working Capital | 196 | -371 | -467 | 239 | -42 |
| Other Operating Activity | -1,184 | 229 | 48 | 753 | -391 |
| Operating Cash Flow | $-32 | $84 | $-180 | $496 | $195 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -235 | 959 | -1,217 | -2,021 | -1,160 |
| Purchase Of Investment | N/A | N/A | N/A | -152 | N/A |
| Purchase Sale Intangibles | -442 | -1,459 | 207 | N/A | N/A |
| Other Investing Activity | 0 | -1,459 | 207 | 0 | 0 |
| Investing Cash Flow | $-677 | $-500 | $-1,010 | $-2,173 | $-1,160 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -30 | N/A | N/A | 0 | 0 |
| Debt Issued | 250 | 596 | 99 | 51 | 614 |
| Debt Repayment | -81 | -54 | -48 | -48 | -47 |
| Common Stock Issued | 532 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 1,998 | 642 |
| Financing Cash Flow | $671 | $542 | $51 | $2,002 | $1,208 |
| Exchange Rate Effect | N/A | N/A | 0 | 0 | 1 |
| Beginning Cash Position | 104 | -22 | 1,117 | 791 | 547 |
| End Cash Position | 66 | 104 | -22 | 1,117 | 791 |
| Net Cash Flow | $-38 | $127 | $-1,139 | $326 | $243 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32 | 84 | -180 | 496 | 195 |
| Capital Expenditure | -677 | -444 | -1,217 | -2,021 | -1,160 |
| Free Cash Flow | -708 | -360 | -1,397 | -1,525 | -965 |